Brand Name(s): Biaxin; Klacid; Claripen
CAS nº: 81103-11-9
(kla rith roe mye sin)
About Clarithromycin
This reference site is dedicated exclusively to clarithromycin, the generic ingredient more commonly known by its brand names Biaxin®, Klacid® and Claripen®.
This site provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.
Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about clarithromycin, as well as take part in our open discussion forum by sharing your own knowledge and experiences with people who are using this medication.
This unique site will also provide you with inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total clarithromycin experience!
Why is this medication prescribed?
Clarithromycin is a macrolide antibiotic that works by fighting bacteria in your body.
It is used to treat pharyngitis, tonsillitis, acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, pneumonia (especially atypical pneumonias associated with chlamydia pneumoniae or TWAR), skin and skin structure infections, and also in HIV and AIDS patients to prevent, and treat, disseminated mycobacterium avium complex or MAC.
Clarithromycin has been used in combination with Prilosec® in treating H. Pylori bacteria that causes stomach ulcers.
Latest News
Ranbaxy receives USFDA approval for anti-bacterial drug
Ranbaxy Laboratiories Ltd, India's largest drug firm by revenue, on Friday said it has received US...
[more]US court affirms Biaxin patent ruling against Andrx
A U.S. appeals court on Friday upheld a lower court ruling blocking Andrx Pharmaceuticals from...
[more]Involvement of mitochondria and caspase pathways in N-demethyl-clarithromycin-induced apoptosis in human cervical cancer HeLa cell.
AIM: To study the mechanisms by which N-demethyl-clarithromycin (NDC) induces human cervical cancer...
[more]Abbott fails to block copy of antibiotic
Abbott Laboratories has lost a bid to stop Novartis AG's Sandoz unit from selling a generic copy of...
[more]Clarithromycin treatment and QT prolongation in childhood.
The effect of clarithromycin on the QT interval was studied in a group of 28 children treated for...
[more]